Listing 1 - 7 of 7 |
Sort by
|
Choose an application
Coeliac Disease (CD) affects at least 1% of the population. "Classical" CD refers to gastrointestinal presentations with anaemia and gastrointestinal symptoms. CD can, however, present with extraintestinal manifestations, the commonest of which are dermatitis herpetiformis and neurological presentations (e.g., ataxia, neuropathy, encephalopathy). Recognition and research into the pathophysiology of such manifestations is likely to enhance our understanding of this complex autoimmune disorder.
Choose an application
Coeliac Disease (CD) affects at least 1% of the population. "Classical" CD refers to gastrointestinal presentations with anaemia and gastrointestinal symptoms. CD can, however, present with extraintestinal manifestations, the commonest of which are dermatitis herpetiformis and neurological presentations (e.g., ataxia, neuropathy, encephalopathy). Recognition and research into the pathophysiology of such manifestations is likely to enhance our understanding of this complex autoimmune disorder.
Choose an application
Coeliac Disease (CD) affects at least 1% of the population. "Classical" CD refers to gastrointestinal presentations with anaemia and gastrointestinal symptoms. CD can, however, present with extraintestinal manifestations, the commonest of which are dermatitis herpetiformis and neurological presentations (e.g., ataxia, neuropathy, encephalopathy). Recognition and research into the pathophysiology of such manifestations is likely to enhance our understanding of this complex autoimmune disorder.
Choose an application
This dissertation by Hanna Gustafsson Bragde explores the use of biomarkers in the diagnosis of celiac disease (CD), a chronic immune-mediated condition triggered by gluten that affects the small intestine. The study aims to enhance diagnostic accuracy by identifying new biomarkers based on gene expression in small intestinal biopsies and blood samples. Through gene expression profiling, the research identifies specific genes that can differentiate active CD mucosa from normal mucosa and assess the degree of intestinal injury. The findings suggest potential improvements in CD diagnostics, especially in cases with low antibody levels or minor intestinal changes. This work contributes to understanding CD's biological processes and the role of gene expression in diagnostics, offering insights into immune response, intestinal barrier function, and metabolism. It is intended for medical researchers and clinicians focusing on gastrointestinal diseases and diagnostic innovations.
Celiac disease. --- Biochemical markers. --- Celiac disease --- Biochemical markers
Choose an application
In the last few years, an increasing number of individuals have adopted a gluten free diet (GFD). A significant proportion of that includes patients affected by celiac disease (CD), who have to follow a strict GFD for medical purposes. However, a high number of individuals are currently following a GFD without medical counseling and without a specific diagnosis needing a gluten withdrawal from the diet. This is due to the frequently incorrect information diffused on the Internet and mass media on the topic of GFD. For these reasons, research on the GFD and its clinical use and biological effects is urgently needed.
Choose an application
Celiac disease (CD) occurs in about 1% of people worldwide. Diagnosis rates are increasing due to a true rise in incidence, rather than increased awareness and detection. CD affects genetically susceptible individuals who are triggered by the ingestion of gluten. The disease has many clinical manifestations, ranging from severe to minimally symptomatic or non-symptomatic presentations. Diagnosis requires the presence of duodenal chronic inflammation, and most patients have circulating antibodies against tissue transglutaminase. Our understanding of the basic and clinical aspects of CD increases, which is as a major health problem of almost global occurrence. Case finding, distinguishing CD from other gluten-sensitive conditions, better care, and balanced use of resources are the current challenges.
Celiac disease. --- Coeliac disease --- Diarrhea --- Digestive organs --- Malabsorption syndromes --- Diseases --- Life Sciences --- Clinical Immunology --- Immunology and Microbiology --- Pure Immunology
Choose an application
The goal of this Special Issue, "Probiotics and Prebiotics in Pediatrics", is to focus on the importance of pediatric nutrition with probiotics and prebiotics to improve gastrointestinal health in newborn, infants, and children.Specifically, the aim is to clarify if probiotics and prebiotics can influence gut microbiota composition and host-interaction favoring human health and preventing diseases.This new information will provide health care professionals with a widespread, clear and update evidence on probiotics and prebiotics and intestinal gut microbiota in pediatric care.
non-IgE mediated allergy --- n/a --- randomized controlled trials --- infant --- “Probiotics”[Mesh] --- children --- safety --- therapeutic microbiology --- zinc --- prevention --- Lactobacillus --- cow’s milk protein --- constipation --- hepcidin --- infants --- Bifidobacterium --- Bifidobacterium breve --- allergy --- asthma --- functional abdominal pain disorders --- probiotic strain --- formula feeding --- probiotic --- nutritional programming --- 2?-fucosyllactose --- “Pregnancy”[Mesh] --- colic --- iron absorption --- bifidobacteria --- Newborn”[Mesh] --- breast feeding --- neonatal --- diversity --- acute diarrhea --- celiac disease --- human milk oligosaccharide --- acute gastroenteritis --- human milk oligosaccharides --- tolerance acquisition --- iron deficiency anemia --- infantile colic --- Lacto-N-neotetraose --- gluten free diet --- oligosaccharides --- preterm --- preterm infant --- microbial programming --- paediatrics --- Lactobacillus reuteri --- functional constipation --- protein hydrolyzed formulas --- oral rehydration solution --- gluten-free diet --- infant formula --- prebiotic --- Childhood Asthma Control Test --- microbiome --- intestinal transit time --- prebiotics --- sepsis --- probiotics --- microbiota --- “Infant --- lactobacilli --- human milk --- functional gastrointestinal disorders --- inulin --- fecal microbiota --- Bacillus clausii --- peak expiratory flow rate --- breast milk --- immunoglobulin E --- efficacy --- intestinal microbiota --- necrotizing enterocolitis --- pediatrics --- growth --- "Probiotics"[Mesh] --- cow's milk protein --- "Pregnancy"[Mesh] --- Newborn"[Mesh] --- "Infant
Listing 1 - 7 of 7 |
Sort by
|